Filing search / Kineta, Inc. / "Sustainable"

8-K

EX-99.5

KANT Kineta, Inc.

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

products. Kineta may also experience delays in developing a sustainable, reproducible and scalable manufacturing process or transferring that process

424B3

KANT Kineta, Inc.

10 Nov 22

Prospectus supplement

4:21pm

, and/or developing new product candidates from Yumanity’s discovery engine platform; developing a sustainable and scalable manufacturing process … of Kineta’s platform technologies may not ever result in marketable products. Kineta may also experience delays in developing a sustainable, reproducible

8-K/A

EX-99.1

5dxrnt hj1v

3 Feb 21

Other Events

4:59pm

8-K/A

EX-99.2

8kkb0serbl3nc04gba4f

3 Feb 21

Other Events

4:59pm

8-K/A

EX-99.7

ad87v76n ls

3 Feb 21

Other Events

4:59pm

424B3

n9i4sg83h f5bu

12 Nov 20

Prospectus supplement

6:08am